Volume 79, Issue 6, Pages (March 2011)

Slides:



Advertisements
Similar presentations
Lymphatic vessels develop during tubulointerstitial fibrosis
Advertisements

Volume 62, Issue 1, Pages (July 2002)
Volume 88, Issue 5, Pages (November 2015)
Volume 54, Issue 2, Pages (August 1998)
Volume 65, Issue 2, Pages (February 2004)
Volume 65, Issue 5, Pages (May 2004)
Osteopontin expression in human crescentic glomerulonephritis
Podocyte involvement in human immune crescentic glomerulonephritis
Volume 63, Issue 4, Pages (April 2003)
Vivette D D'Agati, MD, Agnes B Fogo, MD, Jan A Bruijn, MD, J
Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification 
Volume 54, Issue 3, Pages (September 1998)
Hypertensive nephrosclerosis in African Americans versus Caucasians
Volume 62, Issue 1, Pages (July 2002)
Morphometric study of arterioles and glomeruli in the aging kidney suggests focal loss of autoregulation1  Gary S. Hill, Didier Heudes, Jean Bariéty 
Volume 58, Issue 1, Pages (July 2000)
Volume 76, Issue 5, Pages (September 2009)
Volume 68, Issue 3, Pages (September 2005)
J.M. Henderson, S. al-Waheeb, A. Weins, S.V. Dandapani, M.R. Pollak 
Volume 69, Issue 10, Pages (May 2006)
G.S. Hill, D. Heudes, C. Jacquot, É Gauthier, J. Bariéty 
Hyperlipidemia aggravates renal disease in B6.ROP Os/+ mice
Patricia L. St. John, Dale R. Abrahamson  Kidney International 
Volume 57, Issue 2, Pages (October 2000)
Volume 54, Issue 6, Pages (January 1998)
Volume 54, Issue 5, Pages (November 1998)
Volume 62, Issue 1, Pages (July 2002)
Volume 55, Issue 6, Pages (June 1999)
Volume 88, Issue 5, Pages (November 2015)
Volume 70, Issue 8, Pages (October 2006)
Volume 71, Issue 1, Pages (January 2007)
Atubular glomeruli in a rat model of polycystic kidney disease
Volume 63, Issue 4, Pages (April 2003)
Lupus Nephritis: Proliferative Forms (WHO III, IV)
HIV-associated immune complex glomerulonephritis with “lupus-like” features: A clinicopathologic study of 14 cases1  Mark Haas, Sadhana Kaul, Joseph A.
G.S. Markowitz, C. Gelber, V.D. D'agati  Kidney International 
Yongji Wang, Megan L. Borchert, Hector F. DeLuca  Kidney International 
Volume 70, Issue 7, Pages (October 2006)
Lymphatic vessels develop during tubulointerstitial fibrosis
M.B. Stokes, A.M. Valeri, G.S. Markowitz, V.D. D'Agati 
Volume 79, Issue 6, Pages (March 2011)
Tarak Srivastava, Robert E. Garola, Joan M. Whiting, Uri S. Alon 
Volume 68, Issue 4, Pages (October 2005)
Volume 70, Issue 8, Pages (October 2006)
Abnormal development of glomerular endothelial and mesangial cells in mice with targeted disruption of the lama3 gene  C.K. Abrass, A.K. Berfield, M.C.
Churg–Strauss syndrome
Volume 72, Issue 3, Pages (August 2007)
HIV-related nephropathy: A South African perspective
Expression of connective tissue growth factor in human renal fibrosis
Volume 73, Issue 9, Pages (May 2008)
Proteinuria and tubulointerstitial lesions in lupus nephritis
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Volume 71, Issue 12, Pages (June 2007)
Myeloproliferative neoplasms cause glomerulopathy
AJKD Atlas of Renal Pathology: Focal Segmental Glomerulosclerosis
Volume 53, Issue 4, Pages (April 1998)
Volume 71, Issue 7, Pages (April 2007)
Volume 57, Issue 5, Pages (May 2000)
C1q Nephropathy American Journal of Kidney Diseases
Volume 70, Issue 2, Pages (July 2006)
Class IV-S versus class IV-G lupus nephritis: Clinical and morphologic differences suggesting different pathogenesis  Gary S. Hill, Michel Delahousse,
Membranous and crescentic glomerulonephritis in a patient with anti-nuclear and anti- neutrophil cytoplasmic antibodies  A. Chang, O. Aneziokoro, S.M.
Volume 67, Issue 3, Pages (March 2005)
Volume 73, Issue 5, Pages (March 2008)
Volume 58, Issue 1, Pages (July 2000)
Volume 80, Issue 9, Pages (November 2011)
Quiz Page Answers May 2006 American Journal of Kidney Diseases
Christopher P. Larsen, MD, Marjorie L. Beggs, PhD, Patrick D
C1q nephropathy: A variant of focal segmental glomerulosclerosis
Alex B. Magil, Kathryn Tinckam  Kidney International 
Presentation transcript:

Volume 79, Issue 6, Pages 635-642 (March 2011) Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. I. Immunohistochemical studies  Gary S. Hill, Khalil El Karoui, Alexandre Karras, Chantal Mandet, Jean-Paul Duong Van Huyen, Dominique Nochy, Patrick Bruneval  Kidney International  Volume 79, Issue 6, Pages 635-642 (March 2011) DOI: 10.1038/ki.2010.466 Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 1 Immunohistochemical studies showing similarities between IgAN and primary FSGS. (a) Capsular adhesions in IgA nephropathy (IgAN). There are numerous capsular adhesions (arrows) without apparent lesions in the underlying tuft. Mesangial deposits in this instance are easily recognized by their red staining. (Inset) Frequently, such adhesions appear to exert traction on Bowman’s capsule. Original magnifications: (Masson’s trichrome (MT))×350, (inset)×650. (b) Focal loss of podocyte staining. Several capillaries (arrows) show loss of staining, including one with an early adhesion, but without evident lesions in the underlying tuft. Some cells lining Bowman’s capsule are also positive. Glomerular epithelial protein 1 (GLEPP-1); original magnification×400. (c) Capsular adhesions. Early adhesions may show only diminution of staining, but larger ones (arrows) show complete loss of synaptopodin staining. Podocyte staining may stop abruptly at sites of proliferative lesions (top). Synaptopodin; original magnification×350. (d) Loss of podocyte staining over active lesions. Podocyte staining stops abruptly at the point where proliferative cells coming in from the capsule reach the tuft. A parietal podocyte (arrow) is positive. GLEPP-1; original magnification×350. (e) Advanced lesion with ‘cobblestone’ epithelium. Monolayer of negatively staining ‘cobblestone’ epithelium overlies line of new collagenous matrix (arrows) surrounding advanced lesion. Synaptopodin staining has disappeared from the center of lesion, but a synaptopodin-positive cell lies free in Bowman’s space. Synaptopodin; original magnification×350. (f) Parietal epithelial cell (PEC) positivity at capsular adhesions. Paired box gene 2 (PAX2)-positive cells are sparsely aligned along Bowman’s capsule in the lower, normal part of the glomerulus. On top, numerous PAX2-positive cells line the capsule and overlie proliferative lesion in flocculus. A round cell in Bowman’s space (arrow) is PAX2 negative. PAX2; original magnification×350. (g) PAX2 positivity in advanced lesion. PAX2-positive cells pass from capsule onto glomerulus forming pseudotubules. Most positive cells can be traced back to the capsule, but rare cells may be found in the interior (arrow) without evident connection to capsule. PAX2; original magnification×350. (h) Wilms’ tumor protein-1 (WT-1) positivity in active lesion. In the normal (lower) portion of the glomerulus, podocytes and occasional PECs are positive. On top, extensive WT-1 positivity is seen along capsule and over tuft lesion. WT-1; original magnification×350. (i) Proliferation of proliferating cell nuclear antigen (PCNA)-positive cells. Numerous positive cells, some definitely PECs and others presumptively PECs, overlie an area of glomerular necrosis. PCNA; original magnification×300. (j) Advanced lesion. Proliferated PCNA-positive cells overlying an active lesion (upper left) are positive. Some ‘cobblestone’ cells (right) are positive, and others are not. A PCNA-positive round cell (arrow) lies free in Bowman’s space. PCNA; original magnification×350. (k) Cytokeratin-positive cells at site of adhesion. Cells behaving as PECs proliferate at the site of adhesion. C2562; original magnification×350. (l) Advanced lesion. PECs and cobblestone cells show strong positivity. Arrows indicate layer of collagenous matrix overlying advanced lesion. CK-8; original magnification×350. Kidney International 2011 79, 635-642DOI: (10.1038/ki.2010.466) Copyright © 2011 International Society of Nephrology Terms and Conditions